Effect of Parental Presence on Anxiety of Children During Induction of Anesthesia (PPIA)

December 5, 2024 updated by: Ghulam Fatima, Liaquat National Hospital & Medical College

Impact of Parental Presence on the Mean Anxiety Level of Children During Anesthesia Induction - A Randomized Controlled Trial

Anxiety is when children feel scared, worried, or nervous before or during anesthesia induction. This can happen because they don't know what's happening, are scared of the hospital or medical equipment, or are worried about being separated from their parents.

When parents are present, they can:

  • Provide emotional support and reassurance
  • Distract the child from scary things
  • Help the child feel more calm and safe This can help reduce the child's anxiety levels.

When parents are not present, children may feel:

  • More scared and anxious
  • Alone and unsupported
  • More worried about what's happening This can increase the child's anxiety levels. we can prepare children and parents beforehand about what will happen
  • Allow parents to be present during anesthesia induction
  • Use distraction techniques like toys or videos
  • Use gentle and calm anesthesia induction techniques By doing these things, we can help reduce anxiety in children and make the experience less scary for them.

Study Overview

Status

Completed

Detailed Description

Induction of pediatric anesthesia represents a highly stressful event for children, often resulting in preoperative anxiety that can impair the child's perioperative experience and result in adverse postoperative outcomes. It has been proposed that parental presence during induction of anesthesia Preoperative anxiety is linked to postoperative maladaptive behaviors, such as pain following surgery, insomnia, conflicts between the child and his parent, separation anxiety, increased urinary frequency during the night, reduced appetite, lack of interest, agitation, and alienation.may be a non-pharmacologic intervention to reduce children's anxiety. In patients with extreme anxiety, unfavorable postoperative behaviors after anesthesia induction are likely to result in long-term issues, which adversely affect the process of recovery, and also develop a feeling of inadequate care. Parental presence at anesthesia induction is the interaction that takes place in the induction room during the course of anesthesia induction between the child, parent, anesthesiologist, and perioperative nurses.

Study Type

Observational

Enrollment (Actual)

75

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Sindh
      • Karachi, Sindh, Pakistan
        • Liaquat National Hospital and Medical College

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

A group of patients selected from a surgical day care units and wards who presented for minor elective surgical procedures.

Description

Inclusion Criteria:

  • Pediatric patients
  • aged 5-10 years
  • minor surgery
  • duration <1 hour
  • ASA 1 and ASA 2 patients

Exclusion Criteria:

  • Patients and attendant refusal
  • Emergency surgeris
  • Renal insuffciency
  • Age less than 5 and more than 10 years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
PPIA: children anesthetized in the presence of parents
PPIA: Children induced during the presence parents to assess the level of anxiety while aneshetizing.
Control group
Control Group: children induced without the parental presence to assess level of anxiety during anesthitizing.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anxiety
Time Frame: minimum 2 to 3 minutes during Induction of anesthesia
Modified yale preoperative anxiety scale (myPAS) assess activity, vocaliztion and Emotional expressivity andstate of apparent arousal. score 4 to 18 4 means no anxiety and 18 means highly anxious
minimum 2 to 3 minutes during Induction of anesthesia

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ghulam Fatima Dr Ghulam Fatima, Liaquat National Hospital and Medical College

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2024

Primary Completion (Actual)

June 10, 2024

Study Completion (Actual)

June 10, 2024

Study Registration Dates

First Submitted

November 25, 2024

First Submitted That Met QC Criteria

November 27, 2024

First Posted (Actual)

November 29, 2024

Study Record Updates

Last Update Posted (Estimated)

December 10, 2024

Last Update Submitted That Met QC Criteria

December 5, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • LNHMC karachi
  • Dr ghulam fatima (Other Identifier: liaquat national hospital)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

  1. *Patient confidentiality*: Sharing IPD could compromise patient confidentiality and anonymity, potentially harming participants or their families.
  2. *Sponsor's intellectual property*: Clinical trial sponsors may consider IPD as their intellectual property, and sharing it could compromise their commercial interests.
  3. *Competitive advantage*: Sharing IPD could provide competitors with valuable insights, potentially eroding the sponsor's competitive advantage.

    Data quality and validation*: IPD may require additional validation and quality control checks before sharing, which can be time-consuming and resource-intensive.

  4. *Methodological limitations*: Sharing IPD without proper context and methodology information may lead to misinterpretation or misuse of the data.
  5. Informed consent*: Participants may not have provided informed consent for their data to be shared, which could raise ethical concerns.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anxiety

Subscribe